Merck said last week its biggest tariff exposure is through Keytruda and it has enough US inventory for this year. It estimated $200 million in additional costs for the levies implemented to date.

Merck CEO Robert Davis spoke about the new state-of-the-art biologics center slated to be based in Wilmington, Delaware that could eventually provide thousands of jobs.

Merck has struck a $1.3 billion deal to buy Eyebiotech, a move that would push the big drugmaker into the large and growing market for eye-care.

Merck invests $895M to expand its De Soto facility, adding 2,500 construction jobs and 200 full-time roles in the growing Kansas animal health corridor.

Germany's Merck KGaA said on Thursday it is in late-stage talks to acquire U.S.-based SpringWorks Therapeutics for about $3.5 billion, a deal that could give it access to a recently approved rare ...

Merck & Co. has discovered how its blockbuster diabetes medications have become contaminated with a potential carcinogen and believes it can resolve the problem by the end of the year.